Thus Alleman et al. [20] treated four RCC cell lines (with promoter methylation and loss of expression of VHL) with 5-aza-2′-deoxycytidine and demonstrated re-expression of VHL and reduced size of xenografted tumours. The gene discussed is VHL; the disease is renal cell carcinoma.